Cite
Kellar E, Bornstein SM, Caban A, et al. Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1. Ther Innov Regul Sci. 2016;50(6):682-696doi: 10.1177/2168479016670689.
Kellar, E., Bornstein, S. M., Caban, A., Célingant, C., Crouthamel, M., Johnson, C., McIntire, P. A., Milstead, K. R., Patterson, J. K., & Wilson, B. (2016). Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1. Therapeutic innovation & regulatory science, 50(6), 682-696. https://doi.org/10.1177/2168479016670689
Kellar, Ed, et al. "Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1." Therapeutic innovation & regulatory science vol. 50,6 (2016): 682-696. doi: https://doi.org/10.1177/2168479016670689
Kellar E, Bornstein SM, Caban A, Célingant C, Crouthamel M, Johnson C, McIntire PA, Milstead KR, Patterson JK, Wilson B. Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1. Ther Innov Regul Sci. 2016 Nov;50(6):682-696. doi: 10.1177/2168479016670689. Epub 2016 Oct 14. PMID: 30231749.
Copy
Download .nbib